Výsledky vyhledávání - "Hayley, Perry"

Akademický článek

The ASCEND study: protocol for a feasibility study to evaluate an early social communication intervention for young children with Down syndrome

Autor: Vesna Stojanovik, Emma Pagnamenta, Emily Seager, Maria Breen, Susie Jennings, Victoria Joffe, Kate Harvey, Elena Pizzo, Hayley Perry

Publikováno v: Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-11 (2022)

Abstract Background Down syndrome is the most common cause of learning disability, affecting approximately 1 in every 700 babies. Children with Down syndrome have particular difficulties with speech and language. This makes it challenging for them to

Externí odkaz: https://doaj.org/article/58b5e52e32ed4be0a720fcc28e980c71

Zobrazit plný text záznamu

Plný text ve formátu HTML

Effects of training parents in dialogic book‐sharing: The Early‐Years Provision in Children's Centers (EPICC) study

Autor: Lynne Murray, Susie Jennings, Hayley Perry, Martin Andrews, Katherine De Wilde, Amber Newell, Alicia Mortimer, Emily Phillips, Xiaonan Liu, Claire Hughes, Edward Melhuish, Leonardo De Pascalis, Corinne Dishington, John Duncan, Peter J Cooper

Publikováno v: EARLY CHILDHOOD RESEARCH QUARTERLY

Shared picture-book reading is well-recognized as beneficial for children’s early language development, especially where ‘dialogic book-sharing’ techniques are used. Possible benefits of dialogic book-sharing to other aspects of child developme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f66bdd62c73c51a308766db722836c59
https://doi.org/10.1016/j.ecresq.2022.07.008

Zobrazit plný text záznamu

Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double‐blind placebo‐controlled study

Autor: Marcus Maurer, Sophie Gisbert, Nicola Williams, Nirav Ratia, Martin Metz, Hayley Perry, Clive Grattan, Alexandra Walker, Odile Dewit, Marion C. Dickson

Publikováno v: British Journal of Clinical Pharmacology. 87:4797-4808

AIMS To explore the safety, tolerability, pharmacokinetics and pharmacodynamics (PD) of GSK2646264 using skin challenge models. METHODS Healthy volunteers (HV) with a positive allergen skin prick test received GSK2646264 (0.5% or 1% ww) and placebo c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4da2984e98cd002cac769ec274cd8c4
https://doi.org/10.1111/bcp.14923

Zobrazit plný text záznamu

Akademický článek

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.

Autor: Emilia Quattrocchi, Mikkel Østergaard, Peter C Taylor, Ronald F van Vollenhoven, Myron Chu, Stephen Mallett, Hayley Perry, Regina Kurrasch

Publikováno v: PLoS ONE, Vol 11, Iss 6, p e0157961 (2016)

OBJECTIVES:To investigate the safety of ofatumumab retreatment in rheumatoid arthritis. METHODS:Patients with active rheumatoid arthritis participating in two phase III trials (OFA110635 and OFA110634) and a phase II extension trial (OFA111752) recei

Externí odkaz: https://doaj.org/article/40848c24a94e463d857780b7fec3fe33

Zobrazit plný text záznamu

The ASCEND study: protocol for a feasibility study to evaluate an early social communication intervention for young children with Down syndrome

Autor: Maria Breen, Hayley Perry, Vesna Stojanovik, Kate Harvey, Susie Jennings, Elena Pizzo, Victoria Joffe, Emma Pagnamenta, Emily Seager

Publikováno v: Pilot and Feasibility Studies, Vol 8, Iss 1, Pp 1-11 (2022)
Pilot and Feasibility Studies

BackgroundDown syndrome is the most common cause of learning disability, affecting approximately 1 in every 700 babies. Children with Down syndrome have particular difficulties with speech and language. This makes it challenging for them to participa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3bd12ec7fa284aacec4f36962b656c6
https://doi.org/10.1186/s40814-022-00968-7

Zobrazit plný text záznamu

Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review

Autor: Elizabeth L Turner, Alyssa C Platt, John A Gallis, Kaitlin Tetreault, Christina Easter, Joanne E McKenzie, Stephen Nash, Andrew B Forbes, Karla Hemming, Christine Adrion, Naseerah Akooji, Hannah Bensoussane, Aneel Bhangu, Jon Bishop, Bernadeta Bridgwood, Eric Budgell, Agnès Caille, Michael Campbell, Shiwei Cao, Claire Louise Chan, Versha Cheed, Michelle Collinson, Andrew Copas, Stephanie N Dixon, Sandra Eldridge, Alice S Forster, Alicia Gill, Bruno Giraudeau, Alan Girling, James Glasbey, Beatriz Goulao, Kelsey L Grantham, Simon Hackett, Thomas Hamborg, Kelly Handley, Monica Harding, Pollyanna Hardy, Catherine A Hewitt, Richard Hooper, Natalie Ives, Kirsty James, Christopher I Jarvis, Ben Jones, Brennan C Kahan, Mona Kanaan, Jessica Kasza, Lindsay Kendall, Caroline Kristunas, Kristie Kusibab, Hui-Jie Lee, Clémence Leyrat, Stephanie J Macneill, Vichithranie W Madurasinghe, James Martin, Ariane M Mbekwe Yepnang, Kara McCormack, Samir Mehta, Mirjam Moerbeek, Kelly Moran, Lazaro Mwakesi Mwandigha, Lee Aymar Ndouga Diakou, Dmitri Nepogodiev, Omar Omar, Laura A Pankhurst, Alice Parish, Smitaa Patel, Hayley Perry, Ines Rombach, Ryan Simmons, Beth Stuart, Yongzhong Sun, Monica Taljaard, Elsa Tavernier, Jennifer A Thompson, Tracy Truong, Joao Ricardo Vissoci, Adam P Wagner, Tongrong Wang, Xueqi Wang, Jeremy Weber, Nina Wilson, Jonathan Wilson, Rebecca Woolley, Siyun Yang, Zidanyue Yang

Publikováno v: The Lancet Global Health, 9(8), e1163. Elsevier BV
Lancet Glob Health

Overstating the impact of interventions through incomplete or inaccurate reporting can lead to inappropriate scale-up of interventions with low impact. Accurate reporting of the impact of interventions is of great importance in global health research

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6202149025f9160793824c8af5b58368
https://researchonline.lshtm.ac.uk/id/eprint/4661704/1/042.pdf

Zobrazit plný text záznamu

Voice hearers’ experiences of the Making Sense of Voices approach in an NHS setting

Autor: Zoe Travers, Joachim Schnackenberg, Dirk Corstens, Lynette Meredith, Hayley Perry, Craig Steel, Emily Greenfield, Eleanor Longden

The ‘Making Sense of Voices’ (MsV), or ‘Maastricht’ approach has become established within large sections of the voice hearing community, as well as being adopted by some professional mental health workers. However, there has been limited res

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b88cde3b1e16160115907f0afbdbdff
https://ora.ox.ac.uk/objects/uuid:47b82480-6ad7-4167-99e1-0d4aa2702498

Zobrazit plný text záznamu

A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development

Autor: Hayley Perry, Paul A. Wilson, Sam J. Garthside, Valerie J. Ludbrook, Michael Binks, Marion C. Dickson

Publikováno v: Inflammation Research. 64:171-183

To investigate Toll-like receptor activation in human skin using tape stripping and imiquimod cream challenges in healthy volunteers.Seventeen male Caucasian subjects underwent a baseline biopsy on their lower back prior to two tape stripping procedu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc49fb1eee1be966389b9128644da53c
https://doi.org/10.1007/s00011-015-0795-z

Zobrazit plný text záznamu

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis:Results from Three Clinical Trials

Autor: Mikkel Østergaard, Regina Kurrasch, Emilia Quattrocchi, Myron Chu, Hayley Perry, Stephen Mallett, Peter C. Taylor, Ronald F van Vollenhoven

Publikováno v: Quattrocchi, E, Østergaard, M, Taylor, P C, van Vollenhoven, R F, Chu, M, Mallett, S, Perry, H & Kurrasch, R 2016, ' Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis : Results from Three Clinical Trials ', PLoS ONE, vol. 11, no. 6, pp. e0157961 . https://doi.org/10.1371/journal.pone.0157961
PLoS ONE
PLoS ONE, 11(6). Public Library of Science
PLoS ONE, Vol 11, Iss 6, p e0157961 (2016)
Quattrocchi, E, Ostergaard, M, Taylor, P C, van Vollenhoven, R F, Chu, M, Mallett, S, Perry, H & Kurrasch, R 2016, ' Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis : Results from Three Clinical Trials ', PLOS ONE, vol. 11, no. 6, e0157961 . https://doi.org/10.1371/journal.pone.0157961

OBJECTIVES: To investigate the safety of ofatumumab retreatment in rheumatoid arthritis.METHODS: Patients with active rheumatoid arthritis participating in two phase III trials (OFA110635 and OFA110634) and a phase II extension trial (OFA111752) rece

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::785ff028d151621cc6bdf62f66076a72
https://research.vumc.nl/en/publications/9b75d253-3158-476d-9d03-4fcb6ad2823e

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání